Literature DB >> 29851341

Cyclic Thiosulfinates and Cyclic Disulfides Selectively Cross-Link Thiols While Avoiding Modification of Lone Thiols.

Daniel P Donnelly1,2, Matthew G Dowgiallo1, Joseph P Salisbury1,2, Krishna C Aluri1,2, Suhasini Iyengar1, Meenal Chaudhari1,2, Merlit Mathew1, Isabella Miele1, Jared R Auclair1,2, Steven A Lopez1, Roman Manetsch1,3, Jeffrey N Agar1,2,3.   

Abstract

This work addresses the need for chemical tools that can selectively form cross-links. Contemporary thiol-selective cross-linkers, for example, modify all accessible thiols, but only form cross-links between a subset. The resulting terminal "dead-end" modifications of lone thiols are toxic, confound cross-linking-based studies of macromolecular structure, and are an undesired, and currently unavoidable, byproduct in polymer synthesis. Using the thiol pair of Cu/Zn-superoxide dismutase (SOD1), we demonstrated that cyclic disulfides, including the drug/nutritional supplement lipoic acid, efficiently cross-linked thiol pairs but avoided dead-end modifications. Thiolate-directed nucleophilic attack upon the cyclic disulfide resulted in thiol-disulfide exchange and ring cleavage. The resulting disulfide-tethered terminal thiolate moiety either directed the reverse reaction, releasing the cyclic disulfide, or participated in oxidative disulfide (cross-link) formation. We hypothesized, and confirmed with density functional theory (DFT) calculations, that mono- S-oxo derivatives of cyclic disulfides formed a terminal sulfenic acid upon ring cleavage that obviated the previously rate-limiting step, thiol oxidation, and accelerated the new rate-determining step, ring cleavage. Our calculations suggest that the origin of accelerated ring cleavage is improved frontier molecular orbital overlap in the thiolate-disulfide interchange transition. Five- to seven-membered cyclic thiosulfinates were synthesized and efficiently cross-linked up to 104-fold faster than their cyclic disulfide precursors; functioned in the presence of biological concentrations of glutathione; and acted as cell-permeable, potent, tolerable, intracellular cross-linkers. This new class of thiol cross-linkers exhibited click-like attributes including, high yields driven by the enthalpies of disulfide and water formation, orthogonality with common functional groups, water-compatibility, and ring strain-dependence.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29851341     DOI: 10.1021/jacs.8b01136

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  5 in total

1.  Anticancer Agents Derived from Cyclic Thiosulfonates: Structure-Reactivity and Structure-Activity Relationships.

Authors:  Amanda F Ghilardi; Elham Yaaghubi; Renan B Ferreira; Mary E Law; Yinuo Yang; Bradley J Davis; Christopher M Schilson; Ion Ghiviriga; Adrian E Roitberg; Brian K Law; Ronald K Castellano
Journal:  ChemMedChem       Date:  2022-05-23       Impact factor: 3.540

2.  Cyclic Thiosulfonates for Thiol-Mediated Uptake: Cascade Exchangers, Transporters, Inhibitors.

Authors:  Takehiro Kato; Bumhee Lim; Yangyang Cheng; Anh-Tuan Pham; John Maynard; Dimitri Moreau; Amalia I Poblador-Bahamonde; Naomi Sakai; Stefan Matile
Journal:  JACS Au       Date:  2022-03-22

3.  Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor.

Authors:  Yan Zou; Yaohua Wei; Yinping Sun; Jie Bao; Feirong Yao; Zekun Li; Fenghua Meng; Chunhong Hu; Gert Storm; Zhiyuan Zhong
Journal:  Theranostics       Date:  2019-10-17       Impact factor: 11.556

Review 4.  Molecular and pharmacological chaperones for SOD1.

Authors:  Gareth S A Wright
Journal:  Biochem Soc Trans       Date:  2020-08-28       Impact factor: 5.407

5.  Inhibitors of thiol-mediated uptake.

Authors:  Yangyang Cheng; Anh-Tuan Pham; Takehiro Kato; Bumhee Lim; Dimitri Moreau; Javier López-Andarias; Lili Zong; Naomi Sakai; Stefan Matile
Journal:  Chem Sci       Date:  2020-11-18       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.